While HLA-I+ cancer cells released key effector cytokines and chemokines, such as CXCL10, CCL4, CCL5, and IFN-γ, HLA-I–deficient cancer cells had a limited release of proinflammatory cytokines. Here, CCL5 is linked to cancer.